Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96


The EBV-encoded latent membrane proteins, LMP2A and LMP2B, limit the actions of interferon by targeting interferon receptors for degradation.

Shah KM, Stewart SE, Wei W, Woodman CB, O'Neil JD, Dawson CW, Young LS.

Oncogene. 2009 Nov 5;28(44):3903-14. doi: 10.1038/onc.2009.249. Epub 2009 Aug 31.


Epstein-barr virus latent membrane protein 2B (LMP2B) modulates LMP2A activity.

Rovedo M, Longnecker R.

J Virol. 2007 Jan;81(1):84-94. Epub 2006 Oct 11.


The Epstein-Barr virus-encoded LMP2A and LMP2B proteins promote epithelial cell spreading and motility.

Allen MD, Young LS, Dawson CW.

J Virol. 2005 Feb;79(3):1789-802. Erratum in: J Virol. 2005 Mar;79(6):3889.


Latent membrane protein 2B regulates susceptibility to induction of lytic Epstein-Barr virus infection.

Rechsteiner MP, Berger C, Zauner L, Sigrist JA, Weber M, Longnecker R, Bernasconi M, Nadal D.

J Virol. 2008 Feb;82(4):1739-47. Epub 2007 Dec 5.


The Epstein-Barr virus encoded latent membrane protein 2A augments signaling from latent membrane protein 1.

Dawson CW, George JH, Blake SM, Longnecker R, Young LS.

Virology. 2001 Oct 25;289(2):192-207.


EBV LMP2A-specific T cell immune responses elicited by dendritic cells loaded with LMP2A protein.

Chen Y, Sun H, Liu G, Wang B, Wang F, Sun B, Yao K.

Cell Mol Immunol. 2009 Aug;6(4):269-76. doi: 10.1038/cmi.2009.36.


Latent Membrane Protein 2 (LMP2).

Cen O, Longnecker R.

Curr Top Microbiol Immunol. 2015;391:151-80. doi: 10.1007/978-3-319-22834-1_5. Review.


The signaling pathways of Epstein-Barr virus-encoded latent membrane protein 2A (LMP2A) in latency and cancer.

Pang MF, Lin KW, Peh SC.

Cell Mol Biol Lett. 2009;14(2):222-47. doi: 10.2478/s11658-008-0045-2. Epub 2008 Dec 13. Review.


Epstein-Barr Virus Latent Membrane Protein 2A (LMP2A) enhances IL-10 production through the activation of Bruton's tyrosine kinase and STAT3.

Incrocci R, Barse L, Stone A, Vagvala S, Montesano M, Subramaniam V, Swanson-Mungerson M.

Virology. 2017 Jan;500:96-102. doi: 10.1016/j.virol.2016.10.015. Epub 2016 Oct 25.


Epstein-Barr virus latent membrane protein 2A (LMP2A) employs the SLP-65 signaling module.

Engels N, Merchant M, Pappu R, Chan AC, Longnecker R, Wienands J.

J Exp Med. 2001 Aug 6;194(3):255-64.


Role of latent membrane protein 2 isoforms in Epstein-Barr virus latency.

Rechsteiner MP, Bernasconi M, Berger C, Nadal D.

Trends Microbiol. 2008 Nov;16(11):520-7. doi: 10.1016/j.tim.2008.08.007. Epub 2008 Oct 3.


Silencing of latent membrane protein 2B reduces susceptibility to activation of lytic Epstein-Barr virus in Burkitt's lymphoma Akata cells.

Rechsteiner MP, Berger C, Weber M, Sigrist JA, Nadal D, Bernasconi M.

J Gen Virol. 2007 May;88(Pt 5):1454-9.


Antibodies to LMP2A/2B in EBV-carrying malignancies.

Lennette ET, Winberg G, Yadav M, Enblad G, Klein G.

Eur J Cancer. 1995 Oct;31A(11):1875-8.


K1 and K15 of Kaposi's Sarcoma-Associated Herpesvirus Are Partial Functional Homologues of Latent Membrane Protein 2A of Epstein-Barr Virus.

Steinbr├╝ck L, Gustems M, Medele S, Schulz TF, Lutter D, Hammerschmidt W.

J Virol. 2015 Jul;89(14):7248-61. doi: 10.1128/JVI.00839-15. Epub 2015 May 6.


Epstein-Barr virus LMP2A suppresses MHC class II expression by regulating the B-cell transcription factors E47 and PU.1.

Lin JH, Lin JY, Chou YC, Chen MR, Yeh TH, Lin CW, Lin SJ, Tsai CH.

Blood. 2015 Apr 2;125(14):2228-38. doi: 10.1182/blood-2014-08-594689. Epub 2015 Jan 28.


Epstein-Barr virus latent membrane protein 2A contributes to anoikis resistance through ERK activation.

Iwakiri D, Minamitani T, Samanta M.

J Virol. 2013 Jul;87(14):8227-34. doi: 10.1128/JVI.01089-13. Epub 2013 May 22.


A novel latent membrane 2 transcript expressed in Epstein-Barr virus-positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapy.

Fox CP, Haigh TA, Taylor GS, Long HM, Lee SP, Shannon-Lowe C, O'Connor S, Bollard CM, Iqbal J, Chan WC, Rickinson AB, Bell AI, Rowe M.

Blood. 2010 Nov 11;116(19):3695-704. doi: 10.1182/blood-2010-06-292268. Epub 2010 Jul 29.


Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma.

Kong QL, Hu LJ, Cao JY, Huang YJ, Xu LH, Liang Y, Xiong D, Guan S, Guo BH, Mai HQ, Chen QY, Zhang X, Li MZ, Shao JY, Qian CN, Xia YF, Song LB, Zeng YX, Zeng MS.

PLoS Pathog. 2010 Jun 3;6(6):e1000940. doi: 10.1371/journal.ppat.1000940.

Supplemental Content

Support Center